tiprankstipranks
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
DYN
Dyne Therapeutics
RESEARCH TOOLSreports
Want to see DYN full AI Analyst Report?

Dyne Therapeutics (DYN) Income Statement

457 Followers

Dyne Therapeutics Income Statement

Last quarter (Q4 2025), Dyne Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Dyne Therapeutics's net income was $-111.95M. See Dyne Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.05M$ -2.24M$ -2.46M$ 0.00$ 0.00
Operating Expenses
$ 466.13M$ 341.64M$ 239.70M$ 170.96M$ 150.03M
Depreciation and Amortization
$ 2.05M$ 2.24M$ 2.46M$ 1.68M$ 1.09M
EBITDA
$ -437.97M$ -315.18M$ -233.48M$ -169.28M$ -148.94M
Operating Income
$ -468.18M$ -343.89M$ -242.16M$ -170.96M$ -150.03M
Other Income/Expenses
$ 21.97M$ 26.47M$ 6.22M$ 2.86M$ 734.00K
Pretax Income
$ -446.21M$ -317.42M$ -235.94M$ -168.10M$ -149.29M
Net Income
$ -446.21M$ -317.42M$ -235.94M$ -168.10M$ -149.29M
Per Share Metrics
Basic EPS
$ -3.47$ -3.37$ -3.95$ -3.23$ -2.93
Diluted EPS
$ -3.47$ -3.37$ -3.95$ -3.23$ -2.93
Weighted Average Shares Outstanding
 128.44M 94.14M 59.68M 51.98M 50.90M
Weighted Average Shares Outstanding (Diluted)
 128.44M 94.14M 59.68M 51.98M 50.90M
Currency in USD

Dyne Therapeutics Earnings and Revenue History